Cargando…
Extravasation of Epirubicin chemotherapy from a port-a-cath causing extensive breast necrosis: Sequential imaging findings and management of a breast cancer patient
Extravasation of chemotherapy is rare with an estimated incidence of 0.01%-7% but can cause significant morbidity, delay in cancer treatment and potential mortality. We present a case of 55-year-old woman with a metastatic right axillary lymph node with no identifiable breast primary, commenced on c...
Autores principales: | Moyle, Penelope, Soh, Chien, Healy, Nuala, Malata, Charles, Forouhi, Parto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441109/ https://www.ncbi.nlm.nih.gov/pubmed/34552682 http://dx.doi.org/10.1016/j.radcr.2021.08.046 |
Ejemplares similares
-
Diagnosis and management of breast implant capsule recurrence following mastectomy and subpectoral implant – innovative use of ADM for reconstruction
por: Soh, Chien Lin, et al.
Publicado: (2022) -
A Port‐A‐Cath in aorta
por: Zoltowska, Dominika, et al.
Publicado: (2018) -
Doxorubicin Extravasation from a Port-a-cath into Pleural Space in a Young Girl: A Case Report and Review of Literature
por: Tom, Alex, et al.
Publicado: (2022) -
Tissue distribution of epirubicin after severe extravasation in humans
por: Nedomansky, Jakob, et al.
Publicado: (2021) -
The successful use of disparate pedicle types for bilateral therapeutic mammaplasties during breast conservation surgery
por: Bellizzi, Annalise, et al.
Publicado: (2021)